Pharmasimple annonce avoir pris une participation de 5% dans Phytocann Group, expert suisse du CBD en Europe
HoudengGoegnies Belgique, le 9 août 2022, 18h Pharmasimple Code ISIN : BE0974302342. Mnémonique: ALPHS annonce la signature d'un partenariat stratégique et financier avec Phytocann Group, entreprise verticalement intégrée et pionnière du CBD en... See more |
|
|
|
|
|
|
|
|
|
|
https://mb.cision.com/Public/18595/3610818/b8115ff58f13dacd_800x800ar.png
Transparency notification FMR LLC
Brussels Belgium, 5 August 2022 =E2=80=93 20:05 CEST =E2=80=93 Regulate=
d information
1. Summary of the notification
Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large =
shareholdings, UCB=C2=A0SA/NV announces that it received a transparency... See more |
|
|
|
|
|
https://mb.cision.com/Public/18595/3610800/ac752e88efb06bb5_800x800ar.png
Disposal of own shares
Brussels Belgium, 5 August 2022 =E2=80=93 20:00 CEST =E2=80=93 Regulate=
d information
In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB announces that, following exercises o=
f stock options by members of its personnel,... See more |
|
|
|
|
|
|
|
|
|
|
https://mb.cision.com/Public/18595/3607782/826d4973ba246892_800x800ar.png
Strong first six months =E2=80=93 UCB with continued delivery and strong=
resilience
=C2=B7 Revenue increased to =E2=82=AC 2.93 billion 5%; 3% CER^1, net sa=
les to =E2=82=AC 2.70 billion 2%; 0% CER =E2=80=93 impacted by generic e=
rosion to Vimpat/U.S. and E Keppra/Japan
=C2=B7 Underlying profitability adj.... | |